ECOR - Electrocore LLC logo

ECOR

Electrocore LLC

Revenue grew 100% of years5Y
Hold

Electrocore develops and commercializes non-invasive vagus nerve stimulation (nVNS) technology for treating migraine and cluster headaches. Its products include gammaCore, a handheld device, and Truvaga wellness solutions for chronic pain management.

⚕️ Healthcare NASDAQ Listed 2018 $ USD
$1,000 invested 5 years ago $614today

Score Overview

1 Year
Score
Net Growth-10.14%
Net TrendShrank
Net Income Consistency
Rev Growth8.94%
Rev TrendGrew
Revenue Consistency
5 Years
Score5.6
Net Growth10.66%
Net Trend40%
Net Income Consistency
Rev Growth6x
Rev TrendEvery year
Revenue Consistency
All Time
Score
Net Growth72.44%
Net Trend63%
Net Income Consistency
Rev Growth35x
Rev TrendEvery year
Revenue Consistency

See the full market ranking →

Electrocore LLC fundamental performance

Between 2020 and 2025, revenue grew from $ 3M to $ 32M and net income went from -$ 23M to -$ 13M. Revenue increased in every one of those 5 years; net income in 2.

Electrocore LLC currently holds a 5-year HDB Score of 5.6 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 9.40
1 Year2025-08-12
$ 4.48109.82%
5 Years2021-08-12
$ 15.30-38.56%
All Time2018-06-22
$ 297.75-96.84%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 34M-$ 15M$ 8M
2025$ 32M-$ 13M$ 11M
2024$ 25M-$ 11M$ 11M
2023$ 16M-$ 18M$ 10M
2022$ 8M-$ 22M$ 17M
2021$ 5M-$ 17M$ 34M
2020$ 3M-$ 23M$ 22M
2019$ 2M-$ 45M$ 24M
IPO2018$ 992.95K-$ 55M$ 68M

Explore beyond ECOR

You're looking at Electrocore LLC. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies